Diabetic Neuropathy, Painful Clinical Trial
Official title:
Preliminary Assessment of the Efficacy of the VascuActive™ Device on Diabetic Peripheral Neuropathy
The purpose of this study is to assess the safety and the preliminary efficacy of treatment
by the VascuActive device on peripheral diabetic neuropathy, and to correlate this effect
with physiologic changes.
Patients will undergo a 4-week period of home treatment by the VascuActive device, and will
be monitored during this period and during a two-month follow-up period for the efficacy of
the device in reducing neuropathic pain, sensation impairment and other signs and symptoms.
n/a
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT04988321 -
Theta Burst Brain Stimulation in Diabetic Neuropathy Patients With Neuropathic Pain: Investigating Neural Mechanisms
|
N/A | |
| Completed |
NCT00385671 -
An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain
|
Phase 4 | |
| Completed |
NCT00159679 -
Pregabalin in the Treatment of Pain Due to Diabetic Peripheral Neuropathy
|
Phase 4 | |
| Completed |
NCT00141401 -
Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.
|
Phase 3 | |
| Active, not recruiting |
NCT04469270 -
Study to Assess Safety and Efficacy of Engensis in Painful Diabetic Peripheral Neuropathy
|
Phase 3 | |
| Completed |
NCT00553475 -
Randomized, Double-Blind, Multicenter, Placebo-Controlled Study Of Pregabalin For Pain Associated With Diabetic Peripheral Neuropathy
|
Phase 3 | |
| Completed |
NCT00381719 -
Safety and Efficacy of AGN 203818 in Patients With Painful Diabetic Peripheral Neuropathy
|
Phase 2 | |
| Completed |
NCT00539175 -
Treatment of Painful Diabetic Neuropathy With Photon Stimulation
|
N/A | |
| Completed |
NCT00058968 -
A Study for the Treatment of Painful Diabetic Neuropathy
|
Phase 3 | |
| Completed |
NCT05029297 -
Study With Two Capsaicin Topic Treatments in Diabetic Neuropathy.
|
Phase 3 | |
| Completed |
NCT02215252 -
A Clinical Trial To Evaluate PF-05089771 On Its Own And As An Add-On Therapy To Pregabalin (Lyrica) For The Treatment Of Pain Due To Diabetic Peripheral Neuropathy (DPN)
|
Phase 2 | |
| Completed |
NCT00785577 -
A Study for Treatment of Pain in Patients With Diabetic Neuropathy.
|
Phase 2 | |
| Completed |
NCT00858351 -
Thermal Biofeedback for the Treatment of Diabetic Neuropathy
|
N/A | |
| Completed |
NCT03047278 -
Transporters for Organic Cations and Glycemic Control in Patients With Neuropathic Pain.
|
Phase 4 | |
| Completed |
NCT01628627 -
Frequency Modulated Neural Stimulation (FREMS) in Symptomatic Diabetic Neuropathy
|
Phase 4 | |
| Completed |
NCT03315598 -
Evaluation of an Effectiveness and Safety of the Electroacupuncture in the Management of Intractable Neuropathic Pain
|
N/A | |
| Completed |
NCT01057693 -
Study Of Pregabalin (Lyrica) In Patients With Painful Diabetic Peripheral Neuropathy
|
Phase 3 | |
| Completed |
NCT01564459 -
Study to Evaluate MK-6096 in the Treatment of Painful Diabetic Neuropathy (PDN) in Adults (MK-6096-021)
|
Phase 2 | |
| Completed |
NCT01089556 -
A Study in Painful Diabetic Neuropathy
|
Phase 3 | |
| Completed |
NCT00501202 -
Study for Safety and Effectiveness of RWJ-333369 (Carsibamate) for the Treatment of Diabetic Peripheral Neuropathy (DPN).
|
Phase 2 |